P3.40. Cross-resistance to platinums in a cisplatin-resistant oral squamous carcinoma cell line, H-1R
β Scribed by Ogoshi, K.; Uzawa, K.; Yamatoji, M.; Kasamatsu, A.; Negoro, K.; Wada, T.
- Book ID
- 119336974
- Publisher
- Elsevier Science
- Year
- 2009
- Weight
- 51 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1744-7895
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr
## Abstract Studies were performed to determine whether novobiocin can be used to enhance cisplatin (CDDP) cytotoxicity in a human smallβcell lung carcinoma cell line, GLC~4~/CDDP, resistant to CDDP. Continuous incubation with novobiocin enhanced the cytotoxicity of CDDP treatment 1.9βfold in the p